MyLymphomaTeam

There are two main subtypes of Mantle Cell Lymphoma (MCL):

1. Classical MCL (more common)
- The blastoid variant is considered most aggressive
- Higher levels of Ki-67 protein indicate faster cell division and more aggressive disease

2. Leukemic non-nodal MCL (10-20% of cases)
- Generally slow-growing (indolent)
- Show Full Answer

There are two main subtypes of Mantle Cell Lymphoma (MCL):

1. Classical MCL (more common)
- The blastoid variant is considered most aggressive
- Higher levels of Ki-67 protein indicate faster cell division and more aggressive disease

2. Leukemic non-nodal MCL (10-20% of cases)
- Generally slow-growing (indolent)
- Associated with better outcomes Doctors will examine your cancer cells under a microscope to determine the subtype. They may also use the MCL International Prognostic Index (MIPI) to help understand your specific case. Additionally, genetic testing may be performed - for example, mutations in the TP53 gene typically indicate a more aggressive form with poorer treatment response.

It's important to discuss your specific test results with your healthcare team, as they can best interpret what your individual markers mean for your treatment plan.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Mantle Cell Lymphoma Prognosis: What Is the Survival Rate

Mantle Cell Lymphoma Stages: Are Most People Diagnosed at Stage 4?